科济药业-B二零二三年中期报告
20231112023630202339202374 183171712-1716 46621 02171 3485 22 P.O. Box 31119Grand PavilionHibiscus Way802 West Bay RoadGrand Cayman KY1-1205Cayman Islands www.carsgen.com 2125B Maples Fund Services (Cayman) LimitedP.O. Box 1093, Boundary HallCricket Square, Grand Cayman KY1-1102Cayman Islands 3A10 46 202363040420226303762820226302023630 2023630(1)38620226303533320226302023630 20236303122,174202212312,26894 Zevor-celCT053 Zevor-cel(R/R MM)B(BCMA)CAR-T202210zevor-cel(NDA)zevor-cel20232024R/RMM2 20231SZ.000963zevor-cel CT041 CT041Claudin18.2CAR-TCT041IICAR-TCT04120234INDClaudin18.2(PC)CT041202352Claudin18.2(GC/GEJ)CT041(GC)PC1b/2CT041-ST-02NCT04404595(GC/GEJ)PCIbCT041-ST-01NCT04581473GC/GEJIICT041-ST-01NCT04581473(NCT03874897) CAR-TCAR-T GMPCAR-T(RTP)CGMPRTPCAR-TGMPRTP700CAR-T I. CAR-TCAR-T 2023 II. CAR-TR/RMMzevor-celCT041IICT011IAB011Ib 1. 2.II Zevor-celCT053BCMA CAR-T Zevor-celR/RMMBCMACAR-TBCMA(scFv)CARCAR-TT zevor-celZevor-celR/RMM201910FDA(RMAT)R/RMM20199EMA(PRIME)R/RMM202012zevor-cel2019FDA2020(EMA)202210 R/R MM2(LUMMICAR STUDY 2NCT03915184)FDA(CBER)202321002025FDABLA1b/2zevor-cel1720229CAR-TCR R/R MMII(LUMMICAR STUDY 1NCT03975907)202210zevor-celzevor-cel20232024R/RMM20221264ASHBCMACAR-TZevorcabtageneAutoleucelIIzevor-celI/IILUMMICAR STUDY 1BCMACAR-T(CT053)1/220211263ASHzevor-celI ( N C T03302403N C T03380039N C T03716856)20228HaematologicascFv BCMA CAR-TI zevor-cel zevor-cel CT041Claudin18.2 CAR-T CT041Claudin18.2CAR-TCT041Claudin18.2GC/GEJPCClaudin18.2GC/GEJPC(BTC)CAR-TClaudin18.2Claudin18.2CAR-TCAR-TFNCCT041FNC CT041Claudin18.2GC/GEJ20221FDARMAT202111EMAPRIMECT041GC/GEJ20209FDA20211EMA CT041IICAR-T GCPC1b/2(CT041-ST-02NCT04404595)CT0412202352025FDACT041GCBLA2022ASCOCT0411bClaudin18.2 CAR-T(CT041)1b GC/GEJII(CT041-ST-01NCT04581473)2024CT041GCNDA20234CT041INDClaudin18.2CT041-ST-05NCT05911217CT041Ib/II2022ASCOClaudin18.2CAR-T(CT041) Ib/II CT041(NCT03874897)20225NatureMedicineClaudin18.2 CAR-TI CT041GC/GEJ CT041 CT011GPC3 CAR-T CT011CAR-T(HCC)GPC3CAR-THCCI 20228(Frontiersin Immunology)CT011-3T CT011 AB011Claudin18.2 AB011Claudin18.2Claudin18.2Claudin-18GC/GEJPCAB011(ADCC)(CDC)Claudin18.2Claudin18.25 AB011INDClaudin18.2AB011Claudin18.2IAB011IAB011INDClaudin18.2 AB011-ST-01I(NCT04400383)AB01120231ASCOGIClaudin18.2AB011(CAPOX)1 AB011 IND IND5CT0180CT0181CT0590CT048CT071 CT0180GPC3TTCT0180 CT0181GPC3T(IL)-7TCT0181 CT0590THANK-uCAR®BCMAR/RMMCAR-TCT0590R/R MM CT048CycloCAR®CAR-TClaudin18.2GC/GEJPCIL-7CCL21CT048CT048GC/GEJPC CT071GC5D(GPRC5D)CAR-TR/R MMCT071R/R MM KJ-C2113CycloCAR®CAR-TKJ-C2113 KJ-C2114THANK-uCAR®CAR-T KJ-C2320CAR-T CAR-T CAR-TCAR-T CAR-T (1)CAR-TCycloCAR®CycloCAR®CAR-TIL-7CCL21IL-7CAR-TCAR-TCCL21TCAR-TCycloCAR-TCycloCAR-TIL-7CCL19CAR-T7×19CAR-TCycloCAR-TTCycloCAR-TCycloCAR®Claudin18.2GPC3CAR-T (2)CRSCAR-Tzevor-celI3CRSIL-6 sFv-εTGPC3scFvCD3εTCRTCRαTCRβCD3γCD3δCD3ζTCRTMHCsFv-εTIL-7TsFv-εTT (3)CAR-TTHANK-uCAR®THANK-uCAR®TCAR-TT(GvHD)(HvGR)TCRβ2(B2M)TCR(HLA)(NK)HLATCAR-TCAR-TNKNKG2ACARTCR-/HLA-CAR-TNKG2ANKCAR-TTHANK-uCAR-TNKNKG2ACARTCR-/HLA-CAR-TNKTHANK-uCAR®CAR-TCAR-TTHANK-uCAR®CAR-T (4)LADAR®LADARCARLADAR®LADARLADARCAR LADAR-CARLADAR®CARLADAR®LADAR-CAR-T LADAR®LADARLADAR®CAR-T CAR-TGPRC5DB7-H3CAR-T 20236303001012022924 GMPCAR-TCAR-T 3,000CAR-T200CAR-TCAR-T95% 7,6002,000CAR-TCAR-T CAR-TCAR-T GMPRTP RTP3,300CAR-T700RTP(CMC)RTPzevor-celCT041 GMPRTPzevor-celCT041CAR-TCAR-T CAR-Tzevor-cel 202312001,025zevor-cel zevor-celzevor-cel HK Inno.N Corporationzevor-cel HK Inno.N Corporation195940CD19BCMACT032zevor-cel50 2023630525 CAR-T2017CAR-TCAR-TCAR-TCAR-TCAR-TCAR-TFDACAR-TCAR-TCAR-Tzevor-celCT041CycloCAR®THANK-uCAR®LADAR® zevor-celCT041CAR-TCAR-TCAR-T III. 2023202263040936820226302023630 202363040420226303762820226302023630 202263031672023630323 20232022630142310zevor-cel200 31231220236304052022630148 2023630820226309 20236303122,174202212312,26894 202363052022123172 20236302022123157 20236305.2250%20225.2250% 20236305.04%202212314.83%0.21% 202212311122023630106 20236302023630 20236309 202363020221231303120236302022123177 2023630 2023630525 IV. • ••••• ••• ••• •••• • •••• ••• I. II. III. C.C.2C.2.1 C.2.1 IV. 20236302023630 V.13.51B(1) 20231113.10(1)3.10A3.213.253.27A 2023393.10(1)3.10A3.213.253.27A 2023630(i)3.10(1)3.10A3.21(ii)3.10(2) 2023743.10(1)3.10(2)3.10A3.21 13.51B(1)20231113961574 2023630XV(a)XV78(b)352(c) (1)2023630198,139,53634.44%CARTBiotechRedelle HoldingHe Xi Holdings Limited Candock Holdings LimitedAccure Biotech Limited69.00%10.20%10.00%10.00%0.80% (2)20212223172023630198,139,53634.44%20236308,888,8881.55%20236305,555,5560.97%248,9772,739,77365,90720236302023630215,572,73037.47% (3)2023630575,323,662 2023630 VII. 2023630XV23336 (1)198,139,536202363034.44%69.00%10.20%10.00%10.00%0.80%(2)20212223172023630198,139,53634.44%20236308,888,8881.55%20236305,555,5560.97%248,9772,739,77365,90720236302023630215,572,73037.47%(3)20236308,888,8881.55%(4)20236305,555,
